Communication on immunisation – building trust
With an emphasis on the concepts of trust and transparency, this guide has been developed to assist those involved in planning and implementing health communication activities to promote immunisation.
Technical guidance on the Introduction of HPV vaccines in European Union countries – an update
In January 2008, a panel of ECDC experts produced the Guidance for the introduction of HPV vaccines in EU countries. Since then, the European Union has come a long way: most countries have implemented national vaccination programmes for adolescent girls and a significant number have also introduced catch-up programmes for young women.
Effectiveness of rotavirus vaccination: Generic study protocols for retrospective case control and cohort studies based on computerised databases
In Europe, routine rotavirus vaccination of infants at the national level has been introduced with one or two vaccine brands in Finland, Austria, Luxembourg and Belgium within well-baby clinics or administered by general practitioners and paediatricians. When introducing a new vaccine, it is crucial to conduct studies evaluating the vaccination’s impact and effectiveness in order to decide on recommendations for its future use.
Let’s talk about hesitancy: enhancing confidence in vaccination and uptake
This guide provides practical evidence-based and peer-reviewed advice for public health programme managers and communicators involved with immunisation services. It identifies ways to enhance people’s confidence in vaccination and addresses common issues which underlie vaccination hesitancy.
Translation is not enough: cultural adaptation of health communication materials
This guide introduces a five-step, stakeholder-based approach to adapting health communication materials. It describes how countries can take any health communication material and create adapted products which reflect national or local realities, needs and assets without losing the scientific correctness, core concepts and messages of the original version.
Interim technical guidance on public health use of influenza antivirals during influenza pandemics
Antiviral drugs are an important addition to the public health arsenal against influenza. This interim guidance discusses the options for their effective use, especially during a pandemic.
Interim technical guidance on use of specific pandemic influenza vaccines during the H1N1 2009 pandemic
This interim guidance outlines the possible strategies that countries may wish to adopt in the deployment of a pandemic-specific vaccine, considering the two objectives of vaccination: protecting those at greatest risk of severe disease and maintaining essential services.
Protocol for cluster investigations to measure influenza vaccine effectiveness in the EU/EEA
Conducting health communication activities on MMR vaccination
This guide presents the reader with a host of ideas on how to effectively communicate on all issues that relate to measles, mumps and rubella (MMR) vaccination.